Unknown

Dataset Information

0

RON signalling promotes therapeutic resistance in ESR1 mutant breast cancer.


ABSTRACT:

Background

Oestrogen Receptor 1 (ESR1) mutations are frequently acquired in oestrogen receptor (ER)-positive metastatic breast cancer (MBC) patients who were treated with aromatase inhibitors (AI) in the metastatic setting. Acquired ESR1 mutations are associated with poor prognosis and there is a lack of effective therapies that selectively target these cancers.

Methods

We performed a proteomic kinome analysis in ESR1 Y537S mutant cells to identify hyperactivated kinases in ESR1 mutant cells. We validated Recepteur d'Origine Nantais (RON) and PI3K hyperactivity through phospho-immunoblot analysis, organoid growth assays, and in an in vivo patient-derived xenograft (PDX) metastatic model.

Results

We demonstrated that RON was hyperactivated in ESR1 mutant models, and in acquired palbociclib-resistant (PalbR) models. RON and insulin-like growth factor 1 receptor (IGF-1R) interacted as shown through pharmacological and genetic inhibition and were regulated by the mutant ER as demonstrated by reduced phospho-protein expression with endocrine therapies (ET). We show that ET in combination with a RON inhibitor (RONi) decreased ex vivo organoid growth of ESR1 mutant models, and as a monotherapy in PalbR models, demonstrating its therapeutic efficacy. Significantly, ET in combination with the RONi reduced metastasis of an ESR1 Y537S mutant PDX model.

Conclusions

Our results demonstrate that RON/PI3K pathway inhibition may be an effective treatment strategy in ESR1 mutant and PalbR MBC patients. Clinically our data predict that ET resistance mechanisms can also contribute to CDK4/6 inhibitor resistance.

SUBMITTER: Dustin D 

PROVIDER: S-EPMC7782501 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC7414578 | biostudies-literature
| S-EPMC8770568 | biostudies-literature
| S-EPMC8699146 | biostudies-literature
| S-EPMC7854521 | biostudies-literature
| S-EPMC10239325 | biostudies-literature
| S-SCDT-10_15252-EMBJ_2022112408 | biostudies-other
| S-EPMC7913953 | biostudies-literature
| S-EPMC6226524 | biostudies-literature
| S-EPMC3218405 | biostudies-literature
| S-EPMC6851347 | biostudies-literature